What is the price target for ALCOR stock?
10 analysts have analysed ALCOR.PA and the average price target is 35.96 EUR. This implies a price increase of 2.44% is expected in the next year compared to the current price of 35.1.
Biocorp (ALCOR.PA) Forecast, Price Target & Analyst Ratings
EPA:ALCOR • FR0012788065
Current stock price
35.1 EUR
+0.1 (+0.29%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Biocorp (ALCOR.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€35.96
Upside
+ 2.44%
From current price of €35.10 to mean target of €35.96, Based on 10 analyst forecasts
Low
€35.35
Median
€35.96
High
€37.28
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for ALCOR.PA. The average price target is 35.96 EUR. This implies a price increase of 2.44% is expected in the next year compared to the current price of 35.1.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.00%
ALCOR.PA was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ALCOR.PA.
In the previous month the buy percentage consensus was at a similar level.
ALCOR.PA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2023 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.456M 0.10% | 10.225M 20.92% | 11.67M 14.13% | 15.141M 29.74% | 22.866M 51.02% | 29.973M 31.08% | N/A | |
| EBITDA YoY % growth | -941.23K -160.17% | 913.84K 197.09% | 133.2K -85.42% | 1.957M 1,369.22% | 4.017M 105.26% | 5.562M 38.46% | N/A | |
| EBIT YoY % growth | -1.605M -283.46% | 137.4K 108.56% | -732.1K -632.82% | 772.5K 205.52% | 2.472M 220.00% | 4.12M 66.67% | N/A | |
| Operating Margin | -18.98% | 1.34% | -6.27% | 5.10% | 10.81% | 13.75% | N/A | |
| EPS YoY % growth | N/A | N/A -8.70% | N/A 221.33% | 0.01 -96.70% | 0.37 3,500.00% | 0.84 127.78% | 11.84 1,301.98% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
39.30%
EPS Next 5 Year
148.12%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
31.93%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
106.34%
EBIT Next 5 Year
N/A
Biocorp / ALCOR.PA Forecast FAQ
What is the expected long term growth rate for Biocorp (ALCOR.PA)?
The expected long term growth rate for Biocorp (ALCOR.PA) is 31.93%.